The Radical Remission Foundation’s mission is to advance and support scientific research on the topic of radical remission, including randomized controlled trials and published case studies.
Harvard Launches Study on Radical Remission
We are thrilled to announce that researchers at Harvard in collaboration with Tufts have officially launched a pilot study to analyze the benefits of the Radical Remission workshop and online course for cancer patients. Specifically, the research study will look at the impact the workshop may have on patients’ quality of life and dietary habits.
This study is led by Michelle Holmes, MD, DrPH, of the Department of Epidemiology, and Junaidah Barnett, PhD, MCH(N), of the Department of Nutrition. Dr. Barnett first conceived the idea in 2017 after reading Radical Remission, and decided to investigate the impact of the 9 healing factors discussed in the book on cancer patients. This pilot study was recently approved by the Harvard T. H. Chan School of Public Health Institutional Review Board.
What this means:
- The team of Harvard and Tufts researchers will then analyze the completed surveys to determine the impact of the nine Radical Remission healing factors on the quality of life and dietary habits of study participants
- Results from this pilot study will be submitted for publication. If we find positive impact of the 9 healing factors, we hope to apply for larger grants to fund a randomized, controlled trial which will study the impact of the nine healing factors in more depth. Stay tuned!
How you can help:
- If you or someone you know is planning to take the Radical Remission in-person workshop or online course, we hope you or they will consider participating in the research study as well! It will be important to fill out the first set of surveys (Baseline Surveys) before beginning the workshop or course. Please contact your Radical Remission trainer to receive an email invitation to participate in the study.
- Donate to support this study! We welcome your donations to help cover the administrative costs of this study. Your donations to our 501c3 non-profit organization, The Radical Remission Foundation, are tax-deductible. Click here to donate.
Dr. Michelle Holmes is the Principal Investigator of the Radical Remission Multimodal Intervention Study. She is an associate professor of medicine at Harvard Medical School and an associate professor in the department of Epidemiology at Harvard School of Public Health. Her research interests include lifestyle factors (diet, weight change, physical activity, and psychosocial factors, common medications like aspirin) affecting quality of life and survival after a cancer diagnosis, as well as the association between diet and breast cancer risk. Other research interests include diet and lifestyle influences on endogenous levels of steroid hormones and insulin-like growth factors, and ethnic differences in obesity and other lifestyle factors affecting chronic disease risk. She co-edited a book on nutrition for cancer survivors published by the American Cancer Society. She has worked with the Nurses’ Health Study since 1997. Since 2007 she has helped to design a collaborative longitudinal study of non-communicable disease (obesity, diabetes, high blood pressure, heart disease, cancer) at 5 sites in sub-Saharan Africa, called the Africa / Harvard School of Public Health Partnership for Cohort Research and Training (PaCT). Since 2015 she is the co-Principal Investigator of the Aspirin for Breast Cancer Trial (abctrial.org), testing whether treating breast cancer patients with aspirin will prevent their breast cancer from recurring.
Dr. Junaidah Barnett is the co-Principal Investigator of the Radical Remission Multimodal Intervention Study. She is currently affiliated with the Harvard School of Public Health, Department of Nutrition. Dr. Barnett’s research interests include determining the impact of diet, lifestyle, the environment, and other factors, on maintenance of optimal health, prevention of diseases, and optimization of healing from diseases. As Principal Investigator/Project Director and/or co-Investigator, Dr. Barnett has successfully designed and conducted over 20 studies. Her research has focused on the associations of foods, food groups, dietary patterns, macro- and micro-nutrients, as well as other lifestyle factors, including physical activity, on various chronic and infectious diseases, and their risk factors. Studies conducted previously included community needs assessment; randomized, double-blind, placebo-controlled nutrition intervention; well-controlled diet; cross-sectional; nutrition education; dietary and physical activity validation; as well as epidemiological studies in populations of diverse demographic, ethnic and age groups (18 to 90 years; N~30-800/study). The geographical areas where these studies have been conducted include Massachusetts, Pennsylvania, and Delaware, as well as nationally (the Nurses’ Health Study and the Health Professionals Follow-Up Study), and internationally in the Philippines, West Malaysia, and Singapore. As Principal Investigator, Dr. Barnett is currently evaluating the effect of the Nutrition Intervention Program of the Hebrew Senior Life Healthy Living Center of Excellence (HLCE) on the quality of life and dietary intake of participants.
About the Radical Remission Foundation
The Radical Remission Foundation was founded by Kelly Turner, PhD, author of the New York Times bestseller Radical Remission, along with a Board of Directors, in order to promote further scientific research on radical remission cases, in the hopes of deepening our understanding of cancer etiology, prevention, and remission. To learn more about Kelly’s work at the Radical Remission Project, including related books, docuseries, films, and more, please visit www.radicalremission.com.
The Radical Remission Foundation is a 501(c)3 non-profit organization in the state of New York. Our federal tax ID number is 82-4453041, and your donations are fully tax-deductible. Please consider donating today!
For questions or more information, please contact us at [email protected]